Dario Amodei and Sam Altman endorse pacing frontier AI as researchers flag bioweapon risks for biotech.
Anthropic CEO Dario Amodei and OpenAI CEO Sam Altman publicly warned that advanced AI carries serious risk. Amodei argued for slowing progress, and Altman said he agrees the frontier needs pacing. Their posts followed researcher Jacob Coxon leaving Anthropic and charging that Anthropic and OpenAI act irresponsibly.
One feared path involves AI helping design, create, and release bioweapons. In 2022, researchers at Collaborations Pharmaceuticals used an AI molecule generator to find potential drugs and instead produced 40,000 molecules with chemical warfare potential in under six hours. Some molecules were more toxic than known nerve agents, and the authors warned AI drug discovery teams about the risk.
Builders and operators face a security problem spanning AI models and lab tools. Large language models can answer scientific questions and provide experiment instructions. Gene editing and synthetic biology tools have become more accessible, and the DIY biology movement has enabled home labs. The University of Hamburg biosecurity researcher Dunja Sabra says a determined person likely would succeed eventually.
Biosecurity experts and AI labs will face pressure to add safeguards around model outputs and lab tools. Watch for clearer screening rules for molecule generators and LLMs that guide experiments. Watch how biotech firms and research groups respond as gene editing and synthetic biology tools spread. No single safeguard will resolve the debate.
What matters
- Anthropic CEO Dario Amodei and OpenAI CEO Sam Altman agreed to pace frontier AI amid bioweapon fears.
- Builders using molecule generators and LLMs must add biosecurity screening to drug discovery workflows.
- Watch whether labs publish biosecurity safeguards for LLM experiment guidance and gene editing tools.
Why it matters
Watch whether labs publish biosecurity safeguards for LLM experiment guidance and gene editing tools.
This GenAI News article was prepared in original wording using reporting and materials published by MIT Technology Review AI. Source reference: https://www.technologyreview.com/2026/09/18/1144329/the-specter-of-ai-enabled-bioweapons-is-a-wake-up-call-for-biotech/.
Drafted by the GenAI News review pipeline.